订阅小程序
旧版功能

ARV-766, a Proteolysis Targeting Chimera (PROTAC) Androgen Receptor (AR) Degrader, in Metastatic Castration-Resistant Prostate Cancer (mcrpc): Initial Results of a Phase 1/2 Study.

Daniel P. Petrylak,Meredith McKean,Joshua Michael Lang, Xin Gao,Robert Dreicer,Daniel M. Geynisman,Tyler F. Stewart, Mitul Gandhi,Leonard Joseph Appleman,Tanya B. Dorff,Gurkamal S. Chatta,Ronald Tutrone, Jose De la Cerda,Elmer Berghorn, Jiachang Gong, Tinghui Yu, Erin Dominy,Edward Chan,Neal D. Shore

Journal of Clinical Oncology（2024）

引用 0|浏览3
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要